Person profile
Public information reviewedIdan Elmelech
Role
Chief Operating Officer at BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT)
BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT)
Chief Operating Officer · Current mandate
C Suite · Us Listed
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 6, 2026
Alpha Registry